Survival Advantage of Both Human Hepatocyte Xenografts and Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of alpha-1 Antitrypsin Genome-Edited Hepatocytes for Treatment of alpha-1 Antitrypsin Deficiency Deficiency
暂无分享,去创建一个
T. Flotte | D. Greiner | L. Shultz | F. Borel | M. Brehm | A. Barzel | Cynthia Greer | Qiushi Tang | Gwladys Gernoux | M. A. Kay | Christian Mueller | Ziqiong Wang